跳至主要内容
临床试验/NL-OMON49766
NL-OMON49766招募中不适用

Immunity to liver-stage Plasmodium falciparum in peripheral and tissue-resident immune cells - Liver-stage T cell and innate cell immunity (LYTIC)

Radboud Universitair Medisch Centrum0 个研究点目标入组 45 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
45

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients (M/F) over 18 years of age undergoing medically-indicated partial
  • liver resection for underlying disease and who have provided written informed

排除标准

  • Patients who have received immunosuppressive and/or cytostatic agents within
  • the past 3 months, with the exception of topical or inhaled steroids.
  • Patients who are known to have infection with humanimmunodeficiency virus
  • (HIV), hepatitis B virus (HBV) or hepatitis C virus (HCV), or other known
  • clinically-relevant immunodeficient states.

研究者

相似试验

Immunity to liver-stage Plasmodium falciparum in... | 临床试验